TG Therapeutics Inc (NASDAQ:TGTX)

16.23
Delayed Data
As of Apr 24
 -0.18 / -1.10%
Today’s Change
4.42
Today|||52-Week Range
20.00
+2.46%
Year-to-Date

Today’s Trading

Previous close16.41
Today’s open16.36
Day’s range16.20 - 16.77
Volume185,147
Average volume (3 months)554,511
Market cap$755.4M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+13.26%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book9.10

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.29+1.12%
ITCIIntra-Cellular Thera...-1.25-5.24%
COCPCocrystal Pharma Inc+0.12+11.32%
INFIInfinity Pharmaceuti...-0.11-0.75%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers